Skip to main content
SpringerLink
Log in

Prognostic Significance of Residual Breast Disease and Axillary Node Involvement for Patients Who Had Primary Induction Chemotherapy for Advanced Breast Cancer

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

We performed this study to determine the prognostic significance of clinical tumor size, pathologic measurement of residual tumor, and number of positive axillary nodes in the surgical specimen relative to overall survival for patients who underwent primary induction chemotherapy for advanced breast cancer.

Methods

Data, collected prospectively between 1997 and 2002, included clinical tumor-node-metastasis stage, age at diagnosis, hormone receptor status, type of preoperative chemotherapy, histological type, surgical procedure, pathologic measurement in centimeters of residual breast tumor, and the number of positive axillary nodes in the surgical specimen. Univariable correlates of residual breast disease were assessed by using the χ2 test. Recursive partitioning analysis was used to determine the prognostic significance of clinical tumor size, residual tumor size, and pathologic node involvement relative to overall survival. Survival was estimated by using the method of Kaplan and Meier and compared by using the log-rank test. A P value of < .05 was considered significant.

Results

Data were available for 85 patients with advanced breast cancer. Although univariable analysis identified increasing age, clinically involved axillary nodes, and a higher clinical tumor-node-metastasis stage as predictors of an increased risk of residual disease, recursive partitioning analysis identified more than three involved axillary nodes in the surgical specimen, with or without any measurable residual breast disease, as the most significant predictor of decreased survival (P < .001).

Conclusions

Pathologic axillary node involvement was the most significant predictor of decreased survival for patients who had undergone primary induction chemotherapy for advanced breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Adair F, Berg J, Joubert L, Robbins GF. Long term follow-up of breast cancer patients: the 30-year report. Cancer 1996;33:1145–50

    Google Scholar 

  2. Hortobagyi GN. Comprehensive management of locally advanced breast cancer. Cancer 1990;66:1387–91

    PubMed  CAS  Google Scholar 

  3. Bear HD. Indications for neoadjuvant chemotherapy for breast cancer. Semin Oncol 1998;25:3–12

    PubMed  CAS  Google Scholar 

  4. Schwartz GF, Birchansky CA, Komarnicky LT, et al. Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer 1994;73:362–9

    PubMed  CAS  Google Scholar 

  5. Jakesz R. The ABCSG: comparison of pre- vs. postoperative chemotherapy in breast cancer patients—four-year results of Austrian Breast & Colorectal Cancer Study Group (ABCSG) trial 7 (abstract). Proc Am Soc Clin Oncol 2001;20:125

    Google Scholar 

  6. Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 1997;15:2483–93

    PubMed  CAS  Google Scholar 

  7. Scholl SM, Fouquet A, Asselain B, et al. Primary versus adjuvant chemotherapy in premenopausal patients with tumors considered too large for breast conserving surgery: preliminary results of a randomised trial. Eur J Cancer 1994;30A:645–52

    Article  PubMed  CAS  Google Scholar 

  8. van der Hage JA, van de Velde CJH, Julien JP, et al. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 2001;19:4224–37

    PubMed  Google Scholar 

  9. Fisher B, Bryant J, Wolmark N, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998;16:2672–85

    PubMed  CAS  Google Scholar 

  10. Pierga JY, Mouret E, Dieras V, et al. Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer. Br J Cancer 2000;83:1480–7

    Article  PubMed  CAS  Google Scholar 

  11. Smith IC, Heys SD, Hutcheon AW, et al. Neoadjuvant chemotherapy in breast cancer. Significantly enhanced response with docetaxel. J Clin Oncol 2002;20:1456–66

    Article  PubMed  CAS  Google Scholar 

  12. Rajan R, Esteva FJ, Symmans WF. Pathologic changes in breast cancer following neoadjuvant chemotherapy: implications for the assessment of response. Clin Breast Cancer 2004;5:235–8

    Article  PubMed  Google Scholar 

  13. Colleoni M, Zahrieh D, Gelber RD, et al. Preoperative systemic treatment: prediction of responsiveness. Breast 2003;12:538–42

    Article  PubMed  CAS  Google Scholar 

  14. Penault-Llorca F, Bouchet MF, Amat S, et al. Induction chemotherapy for breast carcinoma: predictive markers and relation with outcome. Int J Oncol 2003;22:1319–25

    PubMed  CAS  Google Scholar 

  15. Newman LA, Pernick NL, Adsay V, et al. Histopathologic evidence of tumor regression in the axillary lymph nodes of patients treated with preoperative chemotherapy correlates with breast cancer outcome. Ann Surg Oncol 2003;10:713–5

    Article  Google Scholar 

  16. Arimappamagan A, Kadambari D, Srinivasan K, et al. Complete axillary conversion after neoadjuvant chemotherapy in locally advanced breast cancer: a step towards conserving axilla? Indian J Cancer 2004;41:13–7

    PubMed  CAS  Google Scholar 

  17. Kling KM, Ostrzega N, Schmit P. Breast conservation after induction chemotherapy for locally advanced breast cancer. Am Surg 1997;6:861–4

    Google Scholar 

  18. Valagussa P. Prognostic factors in locally advanced noninflammatory breast cancer: long-term results following primary chemotherapy. Breast Cancer Res Treat 1990;15:137–47

    Article  PubMed  CAS  Google Scholar 

  19. Hortobagyi GN. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 1988;62:2507

    PubMed  CAS  Google Scholar 

  20. Zanbetti M. Combined sequential approach in locally advanced breast cancer. Ann Oncol 1999;10:305

    Article  Google Scholar 

  21. Danforth DN, Zujewski J, O’Shaughnessy J, et al. Selection of local therapy after neoadjuvant chemotherapy in patients with stage III A, B breast cancer. Ann Surg Oncol 1998;5:150–8.

    Article  PubMed  Google Scholar 

  22. Schwartz GF, Cantor RI, Biermann WA. Neoadjuvant chemotherapy before definitive treatment for stage III carcinoma of the breast. Arch Surg 1987;122:1430–4

    PubMed  CAS  Google Scholar 

  23. Kuer HM, Newman LA, Fornage BD, et al. Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer. Ann Surg Oncol 1998;5:673–80

    Article  Google Scholar 

  24. Gajdos C, Tartter P, Estabrook A, Gistrak MA, Jaffer S, Bleiweiss IJ. Relationship of clinical and pathological response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer. J Surg Oncol 2002;80:4–11

    Article  PubMed  Google Scholar 

  25. Krag DN, Single RM. Breast cancer survival according to number of nodes removed. Ann Surg Oncol 2003;10:1152–9

    Article  PubMed  Google Scholar 

  26. Lenert JT, Vlastos G, Mirza NQ, et al. Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patients. Ann Surg Oncol 1999;6:762–7

    Article  PubMed  CAS  Google Scholar 

  27. Low JA, Berman AW, Steinberg SM, et al. Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy. J Clin Oncol 2004;22:4067–77

    Article  PubMed  CAS  Google Scholar 

  28. Kaufmann M, von Minckwitz G, Smith R, et al. International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. J Clin Oncol 2003;21:2600–8

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery–Breast Center, The Cleveland Clinic Foundation, The Cleveland Clinic Breast Center, 9500 Euclid Avenue, A10, Cleveland, Ohio, 44195

    Pedro F. Escobar MD, Rebecca J. Patrick MA & Joseph P. Crowe MD

  2. Department of Biostatistics and Epidemiology, The Cleveland Clinic Foundation, The Cleveland Clinic Breast Center, 9500 Euclid Avenue, A10, Cleveland, Ohio, 44195

    Lisa A. Rybicki MS

  3. Department of Surgical Pathology, The Cleveland Clinic Foundation, The Cleveland Clinic Breast Center, 9500 Euclid Avenue, A10, Cleveland, Ohio, 44195

    David Hicks MD

  4. Department of Hematology and Oncology, The Cleveland Clinic Foundation, The Cleveland Clinic Breast Center, 9500 Euclid Avenue, A10, Cleveland, Ohio, 44195

    David E. Weng MD, PhD

Authors
  1. Pedro F. Escobar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rebecca J. Patrick MA
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lisa A. Rybicki MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David Hicks MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. David E. Weng MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Joseph P. Crowe MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pedro F. Escobar MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Escobar, P.F., Patrick, R.J., Rybicki, L.A. et al. Prognostic Significance of Residual Breast Disease and Axillary Node Involvement for Patients Who Had Primary Induction Chemotherapy for Advanced Breast Cancer. Ann Surg Oncol 13, 783–787 (2006). https://doi.org/10.1245/ASO.2006.07.024

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2006.07.024

Keywords

Search

Navigation